years. The average observation period was 3.73 years.
The diagnosis of hypertrophic cardiomyopathy was based on physical findings, electrocardiography, M-mode and cross-sectional echocardiography and left ventriculography. Fifteen patients had left ventricular outflow obstruction. Atrial fibrillation was present in 11 patients at the initial examination at our hospital. Persistent atrial fibrillation appeared thereafter in 3, while 1 patient had several attacks of paroxysmal atrial fibrillation.
All cases suspected of having systemic embolism were admitted to the hospital for evaluation and treatment. The diagnosis of systemic embolism was based on the history, physical findings and brain computed tomography. All patients with stroke fulfilled the diagnostic criteria for cerebral embolism proposed by Hart and coworkers. 4) The echocardiographic measurements were made on 10 consecutive cardiac cycles according to the standard method,5) and the left ventricular ejection fraction was calculated by using the equation proposed by Pombo and coworkers.6) The cardiac output was determined by the thermodilution technique using a balloon tipped flow-directed catheter and a cardiac output computer (model 9520, Edwards Laboratories).
The unpaired Student's t-test was used for comparison of means, while the chi-square significance test was used to assess differences in categorical variables. A p value ofless than 0.05 was considered indicative of a significant difference.
RESULTS
Five of 66 patients (7.6%) died during the follow-up period, while systemic embolism occurred in 6 patients (9.1%). The incidence of systemic embolism was 2.4% per patient year. Five of these patients had stroke, all probably due to cerebral embolism, while a 48-year-old female (Case No. 6) had an episode of femoral artery embolism.
The main clinical findings in the patients with systemic embolism are summarized in Table I . One of these patients (Case No.5) had left ventricular outflow obstruction. Only 1 case (Case No.1) had obvious signs of congestive heart failure. All had atrial fibrillation at the time of the embolic accidents. Thus, 6 of 15 patients (40.0%) with persistent or intermittent atrial fibrillation had systemic embolism, while no patient with persistent sinus rhythm had this complication. One patient had a femoral artery embolism during one of several attacks of paroxysmal atrial fibrillation. The duration of atrial fibrillation before the embolic event ranged from 2 days to 5 years. The blood pressure on examination at our hospital was within normal range Vol.27 No.4 in all patients with systemic embolism, although 1 patient (Case No .4) had a history of hyperte nsion. Obvious evidence of mitral regurgitation or mitral valve prolapse was not seen in any of the above 6 cases.
Jpn. Heart J. July 1986 Major measured parameters of the patients with hypertrophic cardiomyopathy are summarized in Table II in relation to the basic rhythm and presence of systemic embolism. As seen in this table, the cardiothoracic ratio and the cardiac index were significantly greater, while the echocardiographically determined left atrial dimension tended to be greater in the embolism group than in those without systemic embolism with or without atrial fibrillation. The echocardiographically determined left ventricular ejection fraction was slightly reduced in the embolism group, but the difference was not significant.
The frequency of systemic hypertension on examination and/or history was nearly the same in the embolism group (1/6: 16.7%), in those with atrial fibrillation but without systemic embolism (1/9: 11.1%) and in those with persistent sinus rhythm (6/51: 11.8%).
DISCUSSION
The complication of systemic embolism in hypertrophic cardiomyopathy has been considered to be infrequent. According to the recent report by Furlan and coworkers,7) the incidence of stroke was 0.6% per patient year in patients with hypertrophic obstructive cardiomyopathy. Koga and coworkers,8) who followed 136 patients with hypertrophic cardiomyopathy, both obstructive and nonobstructive, showed a similar figure. However, Hardarson and coworkers9) reported a higher figure of 2.0% per patient year in hypertrophic obstructive cardiomyopathy, and the present study revealed a high risk of systemic embolism in patients with hypertrophic cardiomyopathy. During an average observation period of 3.73 years, systemic embolism developed in 6 of 66 patients. Probable cerebral embolism occurred in 5 patients, while femoral artery embolism occurred in 1 patient. The estimated incidence of 2.4% per patient year was similar to corresponding figures in patients with mitral stenosis with atrial fibrillation.10), 11) All systemic embolic events occurred in the presence of atrial fibrillation. Six of 15 patients with persistent or intermittent atrial fibrillation had a systemic embolism during the observation period. The high incidence of systemic embolism in patients with atrial fibrillation with various underlying diseases is well known.10)-15) Although the overall incidence of systemic embolism has been thought to be not very high in hypertrophic cardiomyopathy, several investigators pointed out a rather frequent association of this complication with this disease when associated with atrial fibrillation. According to Glancy and coworkers,16) systemic embolism occurred in 4 of 16 patients with hypertrophic obstructive cardiomyopathy and atrial fibrilla-tion. Koga and coworkers8) reported that cerebrovascular accidents were seen in 2 of 8 cases with hypertrophic cardiomyopathy and persistent atrial fibrillation and 2 of 7 cases with transient atrial fibrillation.
Thus, the possibility may be considered that the high incidence of systemic embolism in the present study resulted from the high incidence of atrial fibrillation.
Atrial fibrillation was present in 15 of 66 patients (22.7%) in the present series, while the incidence of this arrhythmia has been reported to be between 5 and 10% in hypertrophic obstructive cardiomyopathy.8),9), 16) The observation that the echocardiographically measured left atrial dimension was large in those cases with systemic embolism may not be surprising because all these patients had atrial fibrillation.
Enlargement of the left atrium in patients with atrial fibrillation has been reported previously.17),18) However, it was interesting to have found that the left atrial dimension tended to be greater in the embolism group than in those with atrial fibrillation but without systemic embolism.
On the other hand, the cardiac index was significantly decreased in those with systemic embolism. This observation suggests that, in addition to atrial fibrillation, left atrial enlargement and a decrease in cardiac output are important risk factors for systemic embolism in hypertrophic cardiomyopathy.
The relationship between the atrial fibrillation and the decrease in the cardiac output is not obvious. Although the cardiac index was significantly decreased, the echocardiographically determined left ventricular ejection fraction was not decreased in the embolism group. No patients with systemic embolism showed any demonstrable sign of mitral regurgitation, while congestive heart failure was present in only 1 patient with cerebral embolism. The possibility exists that the left atrial enlargement and decrease in cardiac output were the result of a loss of atrial contraction in the presence of decreased left ventricular compliance .
